Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study-Reference-Cited by-同舟云学术

Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study

Published:2018-01-30 Issue:1 Volume:13 Page:e0190146
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Safreed-Harmon Kelly,Hetherington Kristina L.,Aleman Soo,Alho Hannu,Dalgard Olav,Frisch Tove,Gottfredsson Magnus,Weis Nina,Lazarus Jeffrey V.^ORCID,

Funder

Gilead Sciences

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

2. Global hepatitis report, 2017. Geneva: World Health Organization; 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ (accessed 26 October 2017).

3. Action plan for the health sector response to viral hepatitis in the WHO European Region. Copenhagen: World Health Organization Regional Office for Europe; 2016 [working document]. http://www.euro.who.int/__data/assets/pdf_file/0008/315917/66wd10e_HepatitisActionPlan_160555.pdf (accessed 16 September 2017).

4. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study;Lancet Gastroenterol Hepatol,2017

5. Hepatitis C among drug users in Europe: epidemiology, treatment and prevention;M Hickman,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of HCV infection in Europe in the DAA era: Review;Liver International;2024-05-28

2. Micro-elimination: A Key Component of Global Hepatitis C Elimination;Hepatitis C: Epidemiology, Prevention and Elimination;2021

3. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020;International Journal of Circumpolar Health;2021-01-01

4. The hidden risk of health-care-associated hepatitis C virus infection: Scenarios, past, present, and future;Recent Developments in Applied Microbiology and Biochemistry;2021

5. Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017;Substance Abuse Treatment, Prevention, and Policy;2020-06-30